Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The healthcare sector has experienced a 0.79% decline year-to-date, making it the worst performer among the S&P 500's 11 sectors and the only one in negative territory. But unlike other market-laggin
HCA Healthcare is the best-managed U.S. hospital chain, offering essential services and resilient financials, making it a strong buy for diversified portfolios. Recent results show robust revenue and
HCA Healthcare's Q2 earnings rose 24% year over year on stronger patient volumes. EPS for 2025 is expected to be within $25.5-$27, up from the earlier view of $24.05-$25.85.
HCA Healthcare, Inc. (HCA) Q2 2025 Earnings Call Transcript
HCA Healthcare (HCA) came out with quarterly earnings of $6.84 per share, beating the Zacks Consensus Estimate of $6.19 per share. This compares to earnings of $5.5 per share a year ago.
HCA Healthcare raised its 2025 profit forecast on Friday as it expects sustained demand for medical procedures to cushion a hit from U.S. President Donald Trump's potential tariffs.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2025. Key second quarter metrics (all percenta
HCA Healthcare, Inc. HCA will release earnings results for the second quarter before the opening bell on Friday, July 25.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Beyond analysts' top-and-bottom-line estimates for HCA (HCA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended
The Zacks Consensus Estimate for HCA's Q2 EPS and revenues suggests a year-over-year upside despite higher costs and surgery volume pressure.
HCA, THC, UHS, and CYH are showing strength through smart expansions and solid earnings despite hospital industry headwinds.
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE